Anish Kandel (Anderson lab) passed his MSc defence on Aug 4, 2023. His thesis is titled: "The role of CREB3L1 in the regulation of epithelial-to-mesenchymal transition in breast cancer cells".
"Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel"
"Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis"
Riley Plett (Anderson lab) passed her MSc defence on May 4, 2020. Her thesis is titled: "New therapies for CREB3L1-deficient triple negative breast cancer".
"Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation"
Riley received a Master's Award: Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). Her project is titled: " Identification of new drugs to treat triple negative breast cancer".
for receiving a Biomedical Summer Research Project Award from the College of Medicine
"Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase"
Jeremy Marshall (Anderson lab) passed his MSc defence on October 31, 2017. His thesis is titled: "Structural analysis of the p85 BH domain in complex with binding partners and impact of mutations".
"Molecular characterization of breast cancer cell lines through multiple omic approaches"
awarded a Saskatchewan Cancer Agency PDF award
July 2015
June 2016
June 2016
January 2016
June 2015
April 2015
October 2014
October 2014
July 2014
July 2014
June 2014
March 2014
December 2013
